None listed
Conditions
Brief summary
This study evaluates an innovative supportive care intervention to improve the well-being of men diagnosed with prostate cancer. Who is it for? This study is for men who have recently been diagnosed with localised prostate cancer in Queensland. Trial details In this study participants are randomly (by chance) divided into two groups. One group will receive usual care, i.e. currently available resource and support materials. The other group will receive the Living with Prostate Cancer supportive care intervention. This includes the provision of self-management resources in both print and web-based form, as well as access to a study website where participants can interact in group discussions and forums. The intervention also includes group peer support phone calls for participants led by trained peer support volunteers and a specialist prostate cancer nurse counsellor. The duration of this intervention is 6 months. Participants will complete questionnaires at 3, 6 and 12 months after enrolling in the study to evaluate their psychological well-being and quality of life.
Interventions
The multimodal supportive care intervention will include self-management and tele-based group peer support. Self-management resources will be in both print and web-based form. A study website will be provided for participants to access program materials and other resources, and to interact in group discussions and forums. The intervention also includes group peer support calls for participants, co-facilitated by a specialist prostate cancer nurse counsellor and trained peer support volunteers. The groups will have up to 8 members, and will run for six months with monthly teleconferenced meetings. Participants who are randomised to the intervention condition will be mailed the patient materials and allocated to a peer support group immediately after randomisation.
Sponsors
Study design
Eligibility
Inclusion criteria
Patients must: (1) have recently been diagnosed with localised prostate cancer (men will be three to six months post-diagnosis at recruitment); (2) be able to read and speak English; (3) have no previous history of head injury, dementia or psychiatric illness; (4) have no other concurrent cancer; (5) have phone access; (6) have physician clearance to participate in the study.
Exclusion criteria
Participants must not: (1) have prostate cancer recurrence or progression; (2) have advanced prostate cancer; (3) have previous head injury or dementia; (4) be unable to read and write English; (5) be undergoing treatment for another cancer; (6) be advised by their clinician that they should not participate in the study.